Diagnomics IRB

Advancing Genomic Research Through Ethical and Collaborative Science

Diagnomics is committed to advancing human health through innovative genomic, epigenetic, and precision medicine research. Our research activities are conducted under an Institutional Review Board (IRB)-approved framework designed to support a broad range of human genetics and health-related studies while ensuring the highest standards of participant protection, privacy, and ethical oversight.

Our research program enables the collection and analysis of biological specimens and genomic data to support scientific discovery, technology development, clinical validation, publication, and intellectual property generation.

The Diagnomics IRB framework supports a wide variety of research areas, including:

• Human genetics and genomics
• Epigenetics and biological aging research
• Cancer genomics and methylation studies
• Liquid biopsy and molecular diagnostics
• Precision medicine and personalized healthcare
• Population genetics and ancestry studies
• Multi-omics research
• AI-driven genomic and health data analytics
• Biomarker discovery and validation
• Development and validation of laboratory-developed tests (LDTs)

The IRB allows the use of blood, saliva, buccal swab, and other human biological specimens for research purposes under approved protocols and informed consent procedures.

Diagnomics actively collaborates with:

• Universities and academic medical centers
• Hospitals and healthcare systems
• Biotechnology and pharmaceutical companies
• Diagnostic laboratories
• Government and public health institutions
• International research organizations

Our IRB framework is designed to facilitate collaborative and multi-site research projects, including international studies involving third-party research partners. This allows collaborators to leverage Diagnomics' expertise, laboratory capabilities, genomic databases, and bioinformatics resources while maintaining regulatory and ethical compliance.

Research conducted under the Diagnomics IRB framework may support:

• Scientific publications
• Patent development and intellectual property generation
• Biomarker discovery programs
• Product development and analytical validation
• Clinical utility studies
• CLIA laboratory test validation
• Regulatory submissions and supporting scientific evidence packages

Diagnomics maintains strict standards for participant privacy, data security, and specimen management. Research data are de-identified whenever appropriate and managed in accordance with applicable regulatory and ethical requirements. All studies undergo appropriate review to ensure the protection of research participants and the responsible use of genomic information.

We welcome opportunities to collaborate with organizations seeking to advance genomic science, precision medicine, longevity research, molecular diagnostics, and AI-powered healthcare solutions.

Whether your organization requires specimen collection, genomic analysis, biomarker validation, clinical research support, or international collaborative studies, Diagnomics provides an experienced research platform capable of supporting projects from early discovery through translational development.

For research collaboration inquiries, please contact Diagnomics Lab at:

info@diagnomics.com
www.diagnomics.com